Studying on the Polymorphs and the Melting Point of HMP

Article Preview

Abstract:

Polymorphs is present in many crystalline drug, different crystal type tend to produce different effects. Drug quality and curative effect of the important quality index is drug heteromorphic stability .The change of drug heteromorphic will change the nature, quality, efficacy of the drug. Generally speaking, the greater the crystal particle size, heating melting needs more energy, the more stable. The crystal type which has high melting point, the chemistry stability is good, but the solubility and digestion rate is low. HMP has different polycrystalline forms, at present reports in the literature there are two kinds of crystal type, form Ⅰ and form Ⅱ. The form Ⅰ is more stable than form Ⅱ, and has higher melting point. This article research the relationship between HMP polymorphism and melting point based with the drug melting point meter and DSC.

You might also be interested in these eBooks

Info:

Periodical:

Pages:

1661-1665

Citation:

Online since:

February 2013

Export:

Price:

Permissions CCC:

Permissions PLS:

Сopyright:

© 2013 Trans Tech Publications Ltd. All Rights Reserved

Share:

Citation:

[1] Chinese Pharmacopoeia Commission, Chinese Pharmacopoeia (The second part) [M]. Beijing: Chemical Industry Press, 2005: 445-446.

Google Scholar

[2] Chinese Pharmacopoeia Commission, Chinese Pharmacopoeia (1990 the second part . Pharmacopoeia comments) [M]. Beijing: Chemical Industry Press, 1993: 579-581.

Google Scholar

[3] Li Xiumei, Zhao Xinxin, China Pharmaceuticals, 2011, 20(12): 37-38.

Google Scholar

[4] Zheng zhen, New Chinese Medicine, 2003, 73 (S1): 90-91.

Google Scholar

[5] Frederick Schatz, Edward Kuczynski, science direct, 2006, 768-775.

Google Scholar

[6] Kloosterboer HJ. Tissue-selectivity, Maturitas 2004; 48(Suppl. 1): S30-40(review).

Google Scholar

[7] Rymer JM, Gynecol Endocrinol 1998, 12(3): 213-20.

Google Scholar

[8] Sun Yuehong, State Intellectual Property Office of the People's Republic of China[P]. 2004, 10, 6: CN1534041A.

Google Scholar

[9] YinYin, YangFeng, ZhangXinrong, Journal of Pharmaceutical practice, 2008, 2 (3): 6-8.

Google Scholar

[10] Ding Xuhuai, Tan Qiu, Chemical Industry press. 1985, 1-29, 74-136.

Google Scholar

[11] Lin Kejiang, Chen Wei, You Qidong, Acta Pharmaceutica Sinica, 2002, 11(1): 46-49.

Google Scholar